Histological features of early hepatocellular carcinomas and their developmental process: For daily practical clinical application

Hepatology International

Volumn 3, Issue 1, 2009, Pages 283-293

  Kondo, Fukuo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Biopsy diagnosis; Early hepatocellular carcinoma; Indistinct margin nodules; Stromal invasion

Indexed keywords

CYTOKERATIN 7;

AUTOPSY; CANCER GROWTH; CANCER INVASION; CANCER MORPHOLOGY; CANCER STAGING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR DIFFERENTIATION;

EID: 59749086077     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-008-9107-9     Document Type: Review

References (40)

1. Liver Cancer Study Group of Japan. The General Rules of the Clinical and Pathological Study of Primary Liver Cancer. 5th ed. Tokyo: Kanehara; 2008
2. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178. doi: 10.1016/0046-8177(91)90039-R
3. Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver 1987;7:18-26
4. Kondo F, Hirooka N, Wada K, Kondo Y. Morphological clues for the diagnosis of small hepatocellular carcinomas. Virchows Arch A Pathol Anat Histopathol 1987;411:15-21. doi: 10.1007/BF00734509
5. Nakashima O, Sugihara S, Kage M, Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins. Hepatology 1995;22:101-105
6. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998;28:1241-1246. doi: 10.1002/hep.510280511
7. Kondo F, Ebara M. Early hepatocellular carcinoma; carcinogenesis, morphology and developmental fashion. Shokakika Jpn 1992;16:409-417
8. Kondo F, Kondo Y, Ebara M, Ohto M. Biopsy diagnosis of small and well differentiated hepatocellular carcinoma. Pathol Clin Med Jpn 1993;11:943-951
9. Kondo F, Wada K, Nagato Y, Nakajima T, Kondo Y, Hirooka N, et al. Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 1989;9:751-755. doi: 10.1002/ hep.840090516
10. Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: A prospective study. Gastroenterology 1998;115:1216-1222. doi: 10.1016/S0016-5085(98)70093-9
11. Roncalli M. Hepatocellular nodules in cirrhosis: Focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 2004;10:S9-S15
12. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000;33:282-289. doi: 10.1016/S0168-8278(00)80369-4
13. Kondo Y, Kondo F, Wada K, Okabayashi A. Pathologic features of small hepatocellular carcinoma. Acta Pathol Jpn 1986;36:1149-1161
14. Kondo F, Kondo Y, Nagato Y, Tomizawa M, Wada K. Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views. J Gastroenterol Hepatol 1994;9:604-612. doi: 10.1111/j.1440-1746.1994.tb01569.x
15. Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K. Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997;17:41-46
16. Miyao Y, Ozaki D, Nagao T, Kondo Y. Interstitial invasion of well-differentiated hepatocellular carcinoma and subsequent tumor growth. Pathol Int 1999;49:208-213. doi: 10.1046/j.1440-1827.1999.00848.x
17. Park YN, Kojiro M, Di Tommaso L, Dhillon AP, Kondo F, Nakano M, et al. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 2007;109:915-923. doi: 10.1002/cncr.22460
18. Ohto M, Kondo F, Ebara M. Pathology, diagnosis, and treatment for small liver cancer. In Tobe T, et al., editors. Primary Liver Cancer in Japan. Tokyo: Springer-Verlag; 1992. 365-373
19. Wada K, Kondo F, Kondo Y. Large regenerative nodules and dysplastic nodules in cirrhotic livers: A histopathologic study. Hepatology 1988;8:1684-1688. doi: 10.1002/hep.1840080636
20. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-993
21. Kondo F, Ebara M, Sugiura N, Wada K, Kita K, Hirooka N, et al. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 1990;12:592-598. doi: 10.1002/hep.1840120324
22. Theise ND, Schwartz M, Miller C, Thung SN. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 1992;16:949-955. doi: 10.1002/hep.1840160416
23. Hytiroglou P, Theise ND, Schwartz M, Mor E, Miller C, Thung SN. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 1995;21:703-708
24. Kondo F, Koshima Y, Ebara M. Nodular lesions associated with abnormal liver circulation. Intervirology 2004;47:277-287. doi: 10.1159/000078479
25. Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007;45:725-734. doi: 10.1002/hep.21531
26. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, et al. Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003;37:198-207. doi: 10.1053/jhep.2003.50022
27. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, et al. Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:89-97. doi: 10.1016/ S0016-5085(03)00689-9
28. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005;18:1591-1598
29. Libbrecht L, Severi T, Cassiman D, Vander Borght S, Pirenne J, Nevens F, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006;30:1405-1411. doi: 10.1097/01.pas.0000213323.97294.9a
30. Gebhardt R, Tanaka T, Williams GM. Glutamine synthetase heterogeneous expression as a marker for the cellular lineage of preneoplastic and neoplastic liver populations. Carcinogenesis 1989;10:1917-1923. doi: 10.1093/carcin/10.10.1917
31. Christa L, Simon MT, Flinois JP, Gebhardt R, Brechot C, Lasserre C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 1994;106:1312-1320
32. Child CG. The Liver and Portal Hypertension. MPCS. Philadelphia: WB Saunders; 1964. 50
33. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649. doi: 10.1002/bjs.1800600817
34. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005;25:133-142. doi: 10.1055/s-2005-871193
35. Kojiro M. Pathology of early HCC: Progression from early to advanced. Hepatogastroenterology 1998;45:1203-1205
36. Maeda T, Adachi E, Kajiyama K, Takenaka K, Honda H, Sugimachi K, et al. CD34 expression in endothelial cells of small hepatocellular carcinoma: its correlation with tumour progression and angiographic findings. J Gastroenterol Hepatol 1995;10:650-654. doi: 10.1111/ j.1440-1746.1995.tb01365.x
37. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: Correlation with differentiation. Liver 1999;19:12-18. doi: 10.1111/j.1478-3231.1999.tb00003.x
38. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998;28:751-755. doi: 10.1002/hep.510280322
39. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-338
40. Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, et al. Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology 2004;40:1396-1405. doi: 10.1002/hep.20486